News
18h
SurvivorNet on MSNAn Exciting Option For Difficult-To-Treat HER2+ Gastric Cancer: What New Data Means For PatientsFor the first time, a medicine aimed directly at the HER2 protein improved overall survival after gastric cancer progressed ...
The following is a summary of “Short- and long-term outcomes after perioperative EOX therapy versus upfront surgery for ...
AstraZeneca’s immunotherapy Imfinzi has proven it can help certain patients with early-stage stomach cancer, according to ...
Adding Imfinzi to fluorouracil-based chemo improved event-free survival and response rates in resectable gastric and ...
Patients with newly diagnosed gastric or gastroesophageal junction (GEJ) cancer who received the PD-L1 inhibitor durvalumab ...
In the United States, approximately 55% of resected gallbladder cancer (GBC) patients undergo oncologic surgery without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results